Related Experiment Videos
Derivative 11 marker chromosome in bladder carcinoma
Cancer Genetics and Cytogenetics
|April 15, 1985
Summary
Cytogenetic analysis of bladder carcinomas revealed nonrandom chromosome changes, specifically a rearranged chromosome 11p+ marker in both patients. This finding suggests a potential role for chromosome 11 aberrations in urinary tract tumor development.
Area of Science:
- Cytogenetics
- Oncology
- Urologic Pathology
Background:
- Bladder cancer is a significant health concern with complex genetic underpinnings.
- Understanding chromosomal abnormalities is crucial for elucidating oncogenesis.
Observation:
- Cytogenetic studies were performed on bladder carcinoma samples from two patients using a direct preparation method.
- The chromosome modal numbers for the tumors were 49 and 55, respectively.
Findings:
- Multiple karyotypic alterations were identified in both tumor samples.
- Q-banded chromosome analysis revealed a consistent chromosome 11p+ marker in both cases, with similar banding patterns.
- The presence of a similar derivative chromosome 11 (der(11)) marker in both patients suggests nonrandom chromosomal changes.
Implications:
- The consistent finding of a chromosome 11p+ marker points towards nonrandom chromosomal aberrations in bladder carcinoma.
- These aberrations may play a role in the development of urinary tract tumors.
- Further research into chromosome 11 aberrations could advance our understanding of bladder cancer oncogenesis.